Mental Health
Stanford Neuromodulation Therapy For Treatment-Resistantdepression: A Randomized Controlled Trial Confirming Efficacy, And An EEG Study Providing Insight Into Mechanism Of Actionand a Potentially Predictive Biomarker Of Efficacy
Ian H. Kratter¹, Christopher W. Austelle¹,², Jennifer I. Lissemore¹, Masataka Wada¹,³, Andrew Geoly¹, Anna Chaiken¹, Irakli Kaloiani¹, Noriah Johnson¹, Stephanie Wan¹, Lena Kozyr¹, Ethan Makarewycz¹, Brendan Wong¹, Malvika Sridhar¹, Flint M. Espil¹, Nick Bassano¹, Bora Kim¹, Jarrod Ehrie¹, Adi Maron-Katz¹,...
Neuromodulation in 2025–2026: Clinical Growth and Emerging Impact
By Amanda Liston Neuromodulation continues to gain significant momentum in 2025–2026 as both a clinical treatment approach and a rapidly expanding healthcare sector. Advances in technology, increased acceptance of non-invasive therapies, and growing demand for alternatives to pharmacological treatment have...
Treating the Root of Mental Health: How Neuromodulation Helps Rebalance the Brain
By Amanda Liston Mental health conditions such as depression, anxiety, PTSD, chronic stress, and insomnia are often discussed primarily in terms of symptoms—low mood, fear, poor sleep, irritability, or difficulty concentrating. In clinical practice, however, these symptoms frequently reflect deeper...